From the Journals

Having More Tender Than Swollen Joints Worsens Outcomes in Early Rheumatoid Arthritis


 

TOPLINE:

Having more tender than swollen joints is linked to worse patient-reported outcomes (PROs), particularly in pain interference, social participation, and fatigue, in patients with rheumatoid arthritis (RA).

METHODOLOGY:

  • In early RA, understanding the impact of tender-swollen joint differences (TSJDs) on PROs across multiple domains of health-related quality of life is important to customize personalized therapeutic strategies.
  • This study evaluated the impact of TSJDs on PROs over 1 year in 547 patients (mean age, 56 years; 70% women; mean symptom duration, 5.3 months) with early RA across 18 centers in Canada between January 2016 and August 2022.
  • TSJDs were assessed for 28 joints (six large and 22 small) at baseline and at 3-, 6-, and 12-month visits using the PRO Measurement Information System (PROMIS-29), covering seven domains of health. Higher PROMIS T-scores indicated better health outcomes.

TAKEAWAY:

  • A one-point increase of TSJD was significantly associated with worse PROMIS T-scores in physical function (adjusted regression coefficient [β], −0.27; 95% CI, −0.39 to −0.15) and social participation (β, −0.34; 95% CI, −0.50 to −0.19).
  • A one-point increase in TSJD was also linked to worsened PROMIS symptoms in pain interference (β, 0.49), fatigue (β, 0.34), sleep problems (β, 0.29), anxiety (β, 0.23), and depression (β, 0.20).
  • Large-joint TSJD was particularly associated with worse PROs than small-joint TSJD.
  • The sensitivity analysis validated the reliability of the primary findings regarding the association between joint counts and PROs evaluated by PROMIS-29, even when accounting for C-reactive protein levels in various scenarios or assumptions.

IN PRACTICE:

“Patients with more tender than swollen joints may experience worsening of all seven domains of health, especially pain interference, social participation, and fatigue. Rheumatologists should be alerted to their patients with early RA having more tender than swollen joints, particularly in large joints,” the authors wrote.

SOURCE:

The study was led by Charis F. Meng, MD, Division of Rheumatology, Hospital for Special Surgery, New York. It was published online on May 1, 2024, in Journal of Clinical Rheumatology.

LIMITATIONS:

The study was observational with missing data, which could have impacted the reliability of the results. Most participants were women and White individuals, which could restrict the generalizability of results. The absence of ultrasound for synovitis limited the clinical assessment of patients with RA for information beyond physical examination alone.

DISCLOSURES:

The study was supported and funded by the Inflammatory Arthritis Center and Division of Rheumatology at the Hospital for Special Surgery, New York. One author reported receiving funding from the National Institutes of Health.

A version of this article appeared on Medscape.com.

Recommended Reading

bDMARDs Preserve Renal Function in Most Patients With AA Amyloidosis
MDedge Rheumatology
Cancer Identified Via Serum Metabolites, Lipids in Rheumatic Disease or Paraneoplasia
MDedge Rheumatology
Specialists Are ‘Underwater’ With Some Insurance-Preferred Biosimilars
MDedge Rheumatology
Don’t Leave CVD Risk in RA Undertreated Despite Unresolved Questions
MDedge Rheumatology
Key Risk Factors for Hydroxychloroquine Retinopathy Described in Large Study
MDedge Rheumatology
Cortisol Test Confirms HPA Axis Recovery from Steroid Use
MDedge Rheumatology
No Increased Risk for Fractures Seen With Frequent Steroid Injections for Musculoskeletal Conditions
MDedge Rheumatology
Over-the-Counter Arthritis Supplements Pose Adrenal Danger
MDedge Rheumatology
Clear Coverage Preference for Humira Over Biosimilars Seen in Most Medicare Part D Plans
MDedge Rheumatology
EULAR 2024 Preview: Therapeutics in Development Take Center Stage
MDedge Rheumatology